# A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC

> **NCT03116984** · PHASE3 · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** Transcatheter arterial chemoembolization
- **RADIATION:** External- beam radiotherapy

## Key facts

- **NCT ID:** NCT03116984
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-01
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-04-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03116984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03116984, "A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03116984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*